EXAM 2 cephalosporins, carbapenems, monobactams Flashcards

1
Q

Cephalosporins MOA

A

interfere w/ PBPs on bacterial cell walls
bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cephalosporins MOR

A

Production of b-lactamase enzymes
Alterations in PBPs leading to decreased binding affinity (MRSA, PSRP)
Several have activity against PRSP; one is active against MRSA(ceftaroline)
Alteration of outer membrane leading to decreased penetration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cephalosporin spectrum

A

Lose gram (+) activity w/ increase gram (-) activity as you go 1st -> 2nd -> 3rd -> 4th
Greater b-lactamase stability as you go from 1st -> 2nd -> 3rd -> 4th

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1st gen cephalosporins

A

cefazolin (parenteral)
cephalexin (oral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

1st gen cephalosporin spectrum

A

MSSA (cefazolin drug of choice)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

2nd gen cephalosporins

A

cefuroxime
cefprozil
cefoxitin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2nd gen cephalosporin spectrum

A

MSSA
BDA (cefoxitin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

3rd generation cephalosporins

A

ceftriaxone
ceftazidime
cefpodoxime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

3rd gen cephalosporin spectrum

A

PRSP (ceftriaxone)
pseudomonas (ceftazidime)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

4th generation cephalosporin

A

cefepime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cefepime spectrum

A

PRSP
MSSA
Pseudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

anti-MRSA cephalosporin

A

Ceftaroline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ceftaroline spectrum

A

PRSP
skin and soft tissue MRSA
MSSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cefiderocol spectrum

A

Fetroja

ESBLs, AMPCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

cephalosporin b-lacatamase inhibitor combos

A

Ceftolozane-tazobactam (zerbaxa)
Ceftazidime-avibactam (avycaz)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ceftolozane-tazobactam (zerbaxa)
Ceftazidime-avibactam (avycaz)
spectrum

A

pseudomonas aeruginosa

17
Q

Which cephalosporin is considered potential drug of choice for MSSA infections?
Ceftazidime
Cefotetan
Cefazolin
Ceftolozane-Tazobactam
Cefnoicid

18
Q

Which cephalosporin does NOT have activity against Pseudomonas aeruginosa?
Ceftriaxone
Ceftazidime
Cefepime
Ceftolozane-Tazobactam
Ceftazidime-Avibactam

A

Ceftriaxone

19
Q

Cephalosporin pharmacology

A

Time>MIC is PD parameter

20
Q

cephalosporin distribution

A

Widely distributed
CSF concentrations ONLY achieved with PARENTAL cefuroxime, 3rd gen and 4th gen agents

21
Q

Cephalosporin elimination

A

Most are primarily eliminated unchanged by kidney
Ceftriaxone (biliary) + Cefoperazone (liver) are NOT eliminated by kidneys

22
Q

what is the half life of cephalosporins?

A

most have <2 hrs t 1/2
ceftriaxone has 8 hr t1/2 –> can give it QD

23
Q

adverse effects of cephalosporins

A

Hypersensitivity
MTT side chain –> hypoprothrombinemia and ethanol intolerance
IV calcium and ceftriaxone precipitates –> nonconvulsice status epilepticus

24
Q

T/F: a patient who developed anaphylaxis to penicillin requiring ICU admission can safety receive any cephalosporin

25
Q

what are the available carbapenems?

A

imipenem
meropenem
ertapenem
doripenem
New agents: meropenem/vaborbactam and imipenem/relebactam

26
Q

carbapenems MOA

A

inhibit cell wall synthesis by binding to PBP
primary target is PBP-2
bactericidal

27
Q

carbapenems MOR

A

b-lactamase production
- highly stable against b-lactamse so drug of choice for AMPc and ESBLs
decrease permeability
alteration in PBPs

28
Q

carbapenems spectrum

A

most broad spectrum agents (liquid jesus or gorilla cillin)
MSSA
pseudomonas (except erta)
BDA (bacteroides)

29
Q

T/F carbapenems are highly stable against b-lactamase enzymes are considered DoC for serious infections due to ESBL and AmpC bugs

30
Q

T/F Meropenem/vaborbactam and imipenem/relabactam were developed to provide activity against KPC producing enterobacterales

31
Q

carbapenems pharmacology

A

Time>MIC like all b-lactams
clinically useful synergy with AMG

32
Q

carbapenems distribution

A

widely distributed in body tissues and fluids
CSF penetration –> meropenem is the only one that gets enough penetration

33
Q

carbapenems elimination

A

all are primarily eliminated unchanged kidneys –> need dose adjustments
short elimination, but ertapenem has t1/2 4 hrs so can give QD dosing

34
Q

imipenem metabolism

A

undergoes hydrolysis by DHP which forms nephrotoxic metabolite
given with cilastatin a DHP inhibitor

35
Q

carbapenem adverse effects

A

hypersensitivity higher
CNS: confusion, dizzy, hallucination, seizures
risk factors: seizures, CNS disorders, high dose, renal insufficiency

36
Q

which carbapenem is co-formulated with cilastatin to prevent DHP degradation in the renal brush border and subsequent nephrotoxicity?
Doripenem
Meropenem
Ertapenem
Imipenem
All carbapenems are co-formulated with cilastatin

37
Q

Monobactam spectrum

A

psuedomonas aeruginosa

38
Q

aztrenoam distribution

A

wide distribution in body tissues and fluids
penetrates CSF in pressence of inflamed meniges

39
Q

Which of the following antibiotics can be used in a patient who developed angioedema, hives, and hypotension requiring ICU admission after an IM injection of penicillin?
Ampicillin
Meropenem
Ceftaroline
Aztreonam
None of the above